Seasoned Lundbeck researcher poached by up-and-coming biotech firm to lead R&D

Biotech company Muna Therapeutics has expanded its leadership team with a new research director, Niels Plath, who the firm has recruited from Lundbeck.

Photo: Lundbeck / PR

Since Muna Therapeutics completed its DKK 450m (USD 70m) capital fundraising round earlier this year, the company has been busily recruiting new profiles to lead the company. In August, the company revealed its new chair of the board, and now, Muna Therapeutics has hired a research director.

This role will be filled by Niels Plath, who has been headhunted from Lundbeck, where he has worked for more than 16 years, most recently as head of global research.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Rumored GN purchase unlikely but not impossible, say analysts

A low value assessment, a high structural value, and no dominant shareholders make GN Group a reasonable investment case for international private equity firms and industrial players. But just how likely is it? Analysts reveal their best bets for what a GN acquisition could look like.

New CFO wants to shake things up at WSA

A mere month into her new job, Marianne Wiinholt, WS Audiology’s fifth chief financial officer since the firm was established through a merger in 2019, is heralding great structural changes.

Further reading

Related articles

Latest news

See all jobs